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Abstract
Introduction South Asia is home to more than
300 million smokeless tobacco (ST) users. Bangladesh,
India and Pakistan as signatories to the Framework
Convention for Tobacco Control (FCTC) have developed
policies aimed at curbing the use of tobacco. The
objective of this study is to assess the compliance of ST
point-of-sale (POS) vendors and the supply chain with
the articles of the FCTC and specifically with national
tobacco control laws. We also aim to assess disparities
in compliance with tobacco control laws between ST and
smoked tobacco products.
Methods and analysis The study will be carried out
at two sites each in Bangladesh, India and Pakistan. We
will conduct a sequential mixed-methods study with five
components: (1) mapping of ST POS, (2) analyses of ST
samples packaging, (3) observation, (4) survey interviews
of POS and (5) in-depth interviews with wholesale dealers/
suppliers/manufacturers of ST. We aim to conduct at least
300 POS survey interviews and observations, and 6–10
in-depth interviews in each of the three countries. Data
collection will be done by trained data collectors. The
main statistical analysis will report the frequencies and
proportions of shops that comply with the FCTC and local
tobacco control policies, and provide a 95% CI of these
estimates. The qualitative in-depth interview data will be
analysed using the framework approach. The findings will
be connected, each component informing the focus and/or
design of the next component.
Ethics and dissemination Ethical approvals for the study
have been received from the Health Sciences Research
Governance Committee at the University of York, UK. In-
country approvals were taken from the National Bioethics
Committee in Pakistan, the Bangladesh Medical Research
Council and the Indian Medical Research Council. Our
results will be disseminated via scientific conferences,
peer-reviewed research publications and press releases.

Strengths and limitations of this study
►► This will be the first multicountry study on the

smokeless tobacco (ST) supply chain in South Asia
that aims to map ST points of sale using geographical information systems.
►► Building on the methods used by the global “Tobacco
Packs Surveillance System” project, our proposed
study will develop/update the inventory of ST products available in Bangladesh, India and Pakistan.
►► Purposive sampling of our main study sites may
decrease the external validity of our methods and
results.
►► Owing to a fear of the relevant authorities, the answers to our survey questions on taxes and finances
might not be completely accurate.
►► We will not be able to do a regression analysis, including shop characteristics, for the pack analysis
component, as we are only collecting unique packs
and not all packs from each shop.

Introduction
Smokeless tobacco (ST) refers to all tobacco
products that are used without burning
the product.1 The International Agency
for Research on Cancer estimates that ST
contains more than 30 carcinogens.2 The use
of ST is associated with an increased incidence
of head, neck and gastrointestinal cancers.3–5
Additionally, ST use is associated with oral
potentially malignant disorders6 and a variety
of other oral and systemic diseases.7 8An
estimated 300 million people around the
globe use ST products in some form, and
the majority (≥85%) of these ST users live
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in South Asia.1 9 The use of ST products is particularly
common in India, Bangladesh and Pakistan, where it is
considered an acceptable social norm.10 This situation is
further complicated by the presence of high amounts of
tobacco-
specific nitrosamines, the main cancer-
causing
agents in tobacco, in the products available in South Asia,
compared with the rest of the world.11
The Framework Convention for Tobacco Control
(FCTC) is a global treaty that aims to enhance tobacco
control measures and incorporate the provisions of the
framework into their national tobacco control laws.12Although the FCTC is aimed at curbing all types of tobacco
use, the focus of tobacco control in most countries has
been on controlling smoking, with control of the non-
smoking forms of tobacco often neglected.13 14 The 2016
Global Progress Report on the implementation of FCTC
highlighted gaps in the formulation and implementation of ST control policies in most parties to the FCTC.15
Bangladesh, India and Pakistan are signatories to the
FCTC and have made variable progress in implementing
the articles of the framework by developing national
tobacco control policies.16
The tightening up of smoking regulations has been
associated with a reported shift from smoking to ST use
in some South Asian countries.9 17 The increase in ST use
can be attributed to a variety of factors, including, but
not limited to, cultural acceptance, perceived safety of ST
products compared with smoking, harm reduction, low
prices and lax or absent ST control laws.14
A 2018 report from the Global Knowledge Hub on
Smokeless Tobacco indicated progress being made with
regards to ST control policies and regulations in South
Asia.14 Many of these regulations and laws are aimed
at demand reduction via various interventions at the
tobacco points of sale (POS), for example, removal of
tobacco products’ displays, and restrictions and bans on
the advertisement of tobacco products at the POS.18 19
The success of these regulations and laws in curbing the
tobacco epidemic in South Asia largely depends on the
degree of compliance with the implementation of these
laws and regulations.20 However, the evidence on the
implementation of the ST control laws and regulations at
the POS in the context of India, Bangladesh and Pakistan
is scarce. Most of the previous work carried out in these
countries focused on tobacco advertisement and promotion at the POS and health warnings on ST packaging,21–26
with little emphasis on the other provisions of the FCTC,
such as sale to/by minors, price and taxation, and provision of viable alternatives. As such, there is a need for a
comprehensive assessment of the compliance of POS in
India, Pakistan and Bangladesh with the local ST control
policies and the specific articles of the FCTC.
This multicountry sequential mixed-methods study aims
to provide a comprehensive assessment of compliance of
ST POS and products with the tobacco control laws in our
three target countries. Furthermore, we aim to elicit information on any disparities between the implementation of
FCTC/local laws for ST and smoking. We will also develop
2

a country-specific inventory of tobacco products, to gain
insight into the diversity of the products available in the
local market, as well as identifying illicit products. Additionally, we will assess the barriers and facilitators to compliance
of the ST wholesale dealers and suppliers with the different
provisions of the FCTC/local laws.

Methods and analysis
Study design
We will conduct a sequential mixed-methods study, incorporating quantitative work (geomapping of ST POS, in-house
analyses of ST products, POS survey interviews and observations) and qualitative work (in-depth-interviews with supply
chain actors, eg, wholesale dealers and suppliers). The
findings from each component will be connected and used
to inform the focus and/or the design of the next component, that is, mapping of the POS will allow us to build a
sampling frame from which we will randomly choose survey
interview respondents. The ST pack analyses will provide us
an insight into manufacturing and sale practices that can
be incorporated into the POS survey interview tool and the
topic guide for in-depth interviews. The findings from the
survey interviews and observations of the POS will guide
the development of country-specific topic guides for the
in-depth interviews.
Study sites
We will conduct this study in Bangladesh, India and Pakistan. In each country, we have purposively selected two sites
based on the use and diversity of the available ST products.
In India, the study will be conducted in the North-East and
North-West districts of Delhi. In Bangladesh, the study will
be conducted in the districts of Dhaka and Rangpur. In Pakistan, the study will be conducted in the districts of Karachi
and Peshawar. In Pakistan and Bangladesh, the selected
sites are the hubs of ST use and manufacture; for India, our
rationale for choosing the sites was based on Delhi being a
metropolitan city with a diverse population and products
and also the logistics available to study team.
Study duration
The data collection will be carried out from 1 June 2019
to 31 December 2020, and analyses will be completed by
30 March 2021.
General sampling strategy
We will use a multistage mixed sampling technique for
the study (figure 1).
Stage 1
Within each of the selected administrative areas (district/
division), we will purposively select one predominantly
urban and one predominantly rural subdistrict. Our study
sites included districts/areas, which comprise urban, peri-
urban and rural areas. We will use the available local government documents, latest census and expert opinion of local
researchers to identify two subdistricts/areas at each site,
Khan Z, et al. BMJ Open 2020;10:e036468. doi:10.1136/bmjopen-2019-036468
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Figure 1 General sampling strategy to be used at all sites. (a) Within each of the selected administrative areas (district/
division), we will purposively select one predominantly urban and one predominantly rural subdistrict. We will use the available
local government documents, latest census and expert opinion of local researchers to identify two subdistricts/areas at
each site, one predominantly urban and the other predominantly rural/peri-urban. (b) We will randomly select three smaller
administrative units per subdistrict. These will be our primary sampling units (PSU). (c) From each PSU, we will randomly select
two enumeration blocks/neighbourhood areas/villages; these will be our secondary sampling units (SSU). (d) From each SSU,
we will recruit up to 13 points of sale (POS). (e) Required sample size/country is 290; through this strategy, we will be able to
recruit up to 312 POS.

one predominantly urban and the other predominantly
rural/peri-urban.
Stage 2
We will randomly select three smaller administrative units
per subdistrict. These will be our primary sampling units
(PSU).
Stage 3
From each PSU, we will randomly select two enumeration
blocks/neighbourhood areas/villages; these will be our
secondary sampling units (SSU).
Data collection (general considerations)
At each study site, we will deploy a team of trained data
collectors to administer the quantitative data collection
instruments (comprising the geomapping, in-house analysis of the ST products packaging, structured POS vendor
survey interview and observation components). Data
collectors will be trained on how to administer the various
study tools beforehand. They will also receive training in
obtaining informed and written/verbal consent. Calibration for the product in-house analysis component will be
done via video conferencing involving study teams from all
sites. A qualitative research specialist will train one person
at each participating site to conduct and transcribe the
in-
depth interviews with the suppliers and/or manufacturers. The data will be monitored for quality and completeness by the site leads/study leads/principal investigator. We
will also conduct small pilot studies in each country to field-
test our study tools.
Khan Z, et al. BMJ Open 2020;10:e036468. doi:10.1136/bmjopen-2019-036468

Data management
The data will be initially collected on a paper-based questionnaire and then transferred to a central database kept on
a secure server at the University of York. Each ST product,
POS vendor, supplier and manufacturer recruited in the
study will be allotted a unique identification number and
the recorded data will not contain any identifiable information about them. Only the study leads/principal investigator/study statistician will have access to the database and
data collection tools. All filled questionnaires will be stored
in locked filing cabinets at the collaborating institutions in
each of the study centres.
In line with the General Data Protection Regulations of
the European Union and the Research Governance Framework for Health and Social Care Research, the data will be
securely archived by the University of York for a minimum
of 5 years after the completion of the study. Following
authorisation from the sponsor, arrangements for confidential destruction will then be made. Recordings from the
in-depth interviews will be deleted at the end of the study. If
an individual withdraws consent for their data to be used, it
will be destroyed without breach of confidentiality.

Study-component-specific methods
POS geomapping
Eligibility criteria for POS
A POS will be eligible for inclusion in the study if it sells
any form of ST. The common types of tobacco POS that
might be eligible for our study are:
1. General/departmental stores.
3
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2.
3.
4.
5.
6.
7.
8.
9.
10.

Petrol pump/gas station stores.
Beer or liquor stores.
Paan (betel quid) shops.
Grocery stores
Exclusive tobacco shops.
Discount shops.
Mobile vendors/carts.
Stationary carts.
Country-specific additional POS types.

Identifying and mapping eligible POS
To identify the eligible POS, we will employ standard
approaches for tobacco POS audits.27 This will entail:
1. Developing a list of tobacco sellers in the selected areas
by collecting the details of local vendors, who have a
license to sell tobacco products (if applicable), and/or
the acquisition of general lists of local businesses/sellers from trade unions and/or local administrative authorities and combining potential tobacco POS from
these lists.
2. This will be followed by ‘ground truthing’ by trained
data collectors, who will visit these shops to ascertain
(a) the existence of the POS and (b) the sale of ST
products at these POS.
3. Once ascertained, each eligible POS will be allotted
a unique identification number and its location will
be recorded via the Google Maps digital application.
The application gives its users their current location
on Google Maps, the Global Positioning System (GPS)
coordinates and the geolocation status.
4. If no prior lists (license holders or businesses/sellers)
are available at the study location(s), our data collection team will do ‘canvassing’ of the ST POS by walking
along all the primary and secondary roads in that area
and identifying eligible ST POS (online supplementary appendix 1).
5. Additionally, we will request each ascertained POS vendor to identify other ST POS, which will be added to
the list.
6. If data collectors observe a mobile vendor during the
ground truthing or canvassing at the study sites, the
area where the team establishes the first contact with
that vendor will be marked as his/her location.
Measuring the density of ST POS
We will collect the most recent official population census
data of our selected study sites from the relevant department(s) in each country. If such data are not available,
we will use unofficial estimates gathered from the local
administration. The density of the POS will be calculated
per 1000 population at our study sites.
Measuring the distance of the POS from schools
We will acquire the list of all schools along with their GPS
coordinates, situated in the selected SSU from the local
education departments. If the data are not available, our
team will visit each school physically, drop a Google Maps
pin at the school gate and record the coordinates. We will
plot all the ST POS and the schools on a digital map to
4

assess if there is compliance with the local laws that ban
the sale of tobacco products in the vicinity (distance will
vary according to country) of the schools.
ST products in-house analysis
Eligibility criteria
All brands of ST products available in the markets at the
study sites will be procured. For a product to be eligible, it
must contain tobacco. The collection of the ST products will
be based on the brand names and not the generic product,
for example, all brands of Gutkha available in the local
market will be collected. Loose products that are not sold
in packaging will be eligible, but only one generic sample
of the product will be procured. The most commonly sold
brand/make of cigarettes, cigars, cigarillos and beedi,
according to the selected vendor, will be procured.
Sample collection and storage
All ST sale shops/vendors identified in the selected SSU
by the geomapping exercise will be approached to procure
the ST products that are available in the local markets. We
will employ an adapted form of the unique packs sampling
technique used for the “Tobacco Packs Surveillance System
(TPackSS)” samples collection.28 One of every unique pack
of ST (any pack with at least one difference in an exterior
feature of the pack including size, brand name, presentation, colours, cellophane, packaging material (ie, hard or
soft tin) and the inclusion of a promotional item) available
in the store will be purchased. This sampling will begin at
a randomly selected eligible vendor. After the purchase at
the initial vendor, at each of the remaining eligible vendors,
one of every ST pack that was not already purchased
at a previous outlet will be purchased. If the selected
vendor does not have any new packs (packs that were not
purchased at another outlet), the sample collection team
will move onto the next eligible vendor. The sample collection will continue until the team has approached the last
eligible vendor. The sample collection team will ascertain
the retail price of each procured pack from the vendor.
They will also ascertain if the prices are inclusive of tax or
not. The sample collection team will neither request nor
accept a reduced price, in case the vendor offers a discount
due to the large quantity being purchased, other than in
those cases where discounted products are already being
offered to all customers as a part of a promotion. All such
general promotions, and individual ‘reduced price’ offers,
will be recorded on a field notes sheet provided to each
data collector.
Product analyses
All the procured samples will be sorted by product type,
and each sample will be allotted a unique identification
number marked on the Ziploc bag with indelible ink. The
study team at each participating institution will analyse one
sample at a time, carefully locking it back in the bag before
moving onto the next sample. A physical inventory of all the
products will be developed at each site and the data related
to the products, for example, unique identification number,
Khan Z, et al. BMJ Open 2020;10:e036468. doi:10.1136/bmjopen-2019-036468
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product family, purchase price and date of purchase, will
be fed into a digital inventory form (online supplementary appendix 2) adapted from the TPackSS inventory data
entry form.
The in-house assessment of the ST products will involve
assessment and recording of their size, price, tax disclosure,
ingredient lists, health warnings, manufacturer details, etc.
Our study tool (online supplementary appendix 3) has been
adapted from the Tobacco Advertisement and Promotion
Surveys (TAPS) standard tools. We will collect the samples
by brand names and assess whether disparities exist between
ST product categories and/or different manufacturers. We
will also collect data on the country of manufacture and
analyse if differences in compliance with the relevant laws
can be explained by differences in the country of manufacture and/or ‘smuggled/illicit’ designation of the product.
The definition of illicit products for each participating site
will be developed after consulting local stakeholders. We
will also analyse the collected cigarette packs, to assess their
compliance with the local laws/FCTC. This will also help us
in the identification of any disparity in the local laws for ST
and those for cigarettes.
POS survey interviews and observation
Sample size
For the POS observation and interviews, we calculated
sample sizes for the individual countries based on the
prevalence of non-compliance with specific provisions of
the local tobacco control laws in the three countries. The
point estimates were derived from the published literature,
that is, 20% of shops selling tobacco to minors in Pakistan,29 19.4% POS non-compliant with Cigarettes and other
Tobacco Products Act (COTPA) regulations regarding
sizing of the advertisements in India30 and 20% POS non-
compliant with tobacco advertisement and promotion laws
in Bangladesh.31
Using the formula sample n=[DEFF*Np(1−p)]/[(d2/
2
Z 1-α/2*(N−1)+p*(1−p)], and assuming a 20% prevalence of
non-compliance, a CI of 95% and an absolute precision of
7%, the sample size for each country came out to be 251.
After accounting for a 15% non-response (based on our
ST supply chain study in Pakistan and Bangladesh),32 the
sample size was rounded up to 290 per country. All sample
size calculations were carried out in OpenEpi software.33
Sampling strategy
We will follow the general sampling strategy (figure 1).
Once a sampling frame of eligible ST POS in each SSU
has been developed through the geomapping, a random
sample of the 13 POS vendors will be recruited from each
SSU.
Recruitment
After providing brief information about the study to the
person in charge of the POS at the time of the store observation, we will formally ask them to provide written consent
to participate in both the POS observation and POS vendor
interview components of the study. Those who do not agree
Khan Z, et al. BMJ Open 2020;10:e036468. doi:10.1136/bmjopen-2019-036468

to participate after receiving the study information will not
be enrolled in the study. The reasons for declining to participate in the study will be recorded. Following consent, the
data collector will proceed to data collection. The consent
provider, who could be either the POS owner (not land-
lords), POS manager or sales assistant(s), will be eligible for
an interview.
Data collection and tools
An adapted version (online supplementary appendix 4) of
the Standardized Tobacco Assessment for Retail Settings
tool34 will be used to record the observations about product
promotion, advertisement, health warnings, etc. We will
observe both the exterior and interior of the shops to assess
compliance with FCTC/local laws. The tool consists of
data fields on health warnings inside and outside the shop,
product advertisement, promotions, display shelves, dummy
packs, product placement, products sold as confectioneries
and cross-promotion. We will also collect similar data for
cigarettes and other smoking products, for comparison.
Our interview tool (online supplementary appendix 5)
has been adapted from a survey instrument that has already
been field-tested in the UK, Bangladesh, Nepal and Pakistan.32 The tool will be translated into local languages at
each study site. In addition to a series of close-ended questions on ST products regarding their supply, sale, popularity,
prices, profits and taxes, the tool also includes similar questions for cigarettes, to allow for comparative analysis. We will
collect data on mediating/moderating variables that could
act as barriers/facilitators to the increased implementation
of the FCTC/local laws. These variables are awareness of
local tobacco control legislation, standards and obligations, awareness of adverse health effects of ST, the effect
of health warnings on sales, market share of ST products,
overall sales related to the availability of tobacco products
for non-
exclusive vendors, incentives by manufacturers/
suppliers, profit margins, regular inspections, penalties for
non-compliance and availability of viable alternatives.
Data analysis
The main statistical analysis will report the frequencies and
proportions of shops that comply with the WHO FCTC and
local tobacco control policies, as measured by the different
items on the survey questionnaire, and provide a 95% CI of
this estimate. We will also provide summaries for the other
categorical variables using frequencies and percentages
and for continuous variables, we will provide means and
SD in addition to a graphical representation. Medians and
IQRs will also be computed if the data are skewed.
We will use logistic regression to explore the bivariate association of compliance with shop characteristics, such as the
type of shop, adjusting for the study design. We will further
expand these regression models to explore the association
of compliance with multiple explanatory variables adjusting
for the study design. Where possible, figures related to ST
sales will be compared with those of cigarette sales, using
similar approaches to the above. We will consider a p-value
of less than 0.05 to be statistically significant. A detailed
5
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statistical analysis plan will be developed before the main
analysis, which will include any a priori subgroup analyses
and strategies for handling missing data. We will use STATA
V.15 for analysis.
In-depth interviews (supply chain)
Participants, sampling and recruitment
At each of the six study sites, we will identify, and collect
contact details of, at least five supply chain actors (from
manufacturers, wholesalers and suppliers) with the help of
the POS survey respondents. From this list, we will purposively recruit three to five participants at each site, ensuring
that the sample includes at least one manufacturer and one
supplier from each site.
Data collection
A topic guide will be developed for the interviews. The
contents of the guide will be based on the findings from the
POS survey. That is, the responses in the survey that warrant
further exploration will be identified by the study teams in
each country and the topic guide aimed at eliciting further
information on the responses will be developed by the qualitative research team. We will start with a standard topic
guide and then tailor it to the findings from the different
countries.
The interviews will be conducted at locations that are
easily accessible to participants, and where they are confident to speak openly, such as their workplaces or the offices
of ward/union council office bearers or the village chief’s
house/hujra. Each interview will last 30–60 min. A trained
researcher will conduct the interviews in the local language.
All interviews will be audio recorded.
Data analysis
The interviews will be transcribed verbatim, translated into
English and analysed using the framework approach.35 The
framework approach is not associated with a particular epistemological viewpoint or theoretical approach and, as such,
is not necessarily concerned with generating social theory.
The approach can be used in inductive or deductive analysis or a combination of the two.36 We will be using an inductive approach and develop a framework matrix, informed
by the study objectives, the interview topics and data from
preliminary interviews. The data from the three countries
will be charted into the same matrix; and then reviewed and
interrogated to compare and contrast views, seek patterns,
connections and explanations within the data, including
comparison across the three countries. Excel software will
aid data handling.
Patient and public involvement
The study is supported by stakeholder groups in each participating country. The stakeholder groups consist of health
professionals, policymakers, representatives from general
society, students and influencers. The stakeholder groups
meet once every year, and so far have been involved in the
design of the study tools, refinement of research questions
and data collection methods. These groups will also be
involved in the dissemination of findings from the study.
6

Ethics and dissemination
We will adhere to the fundamental principles of human
rights as per the Declaration of Helsinki. Ethical approval
has been obtained from the University of York ‘Health
Sciences Research Governance Committee’. This work is
being carried out by the ASTRA Global Health Research
Group (Addressing Smokeless Tobacco use and building
Research capacity in south Asia). Each participating South
Asian institution in ASTRA has obtained ethical approvals
from their institutional/national ethics bodies (online
supplementary appendix 6). All potential participants will
be provided with information regarding the project and
written/verbal consent will be taken from each participant
before recruitment. Consent forms will contain personal
details, including name, date of birth and address.
All information collected during the study will be kept
strictly confidential. There will be restricted access and
disposal arrangements for the participants’ details. Information will be held securely on paper/electronically at the
University of York. The data (other than consent forms)
transferred to or from the University of York will be coded
with a study enrolment number and will not have participants’ identifiers. We have studied the conditions under
which disclosures to law enforcement agencies are required
and are satisfied that the chances of these occurring (criminal activities) are highly unlikely.
To engage our academic audience and the research
fraternity, we will publish the results of the study in peer-
reviewed journals. We will also present our findings at an
international public health conference and an international
tobacco control conference. We will also publish an abstract
of our findings on the websites of all the partner institutions.
We will also present our work to regional research meetings. Additionally, we will incorporate the learning from
this project into academic lectures for master’s students of
public health. We have already established national stakeholder groups in all three target countries, who will guide
the study conduct and help us in the dissemination of our
findings.
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